Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Older Americans Taking More Medications

Andrew M. Seaman  |  March 24, 2016

(Reuters Health)—The proportion of older Americans taking at least five medications or supplements went up in a recent study.

The increase in people using multiple medications paralleled an increase in the number of older Americans at risk for major drug interactions, researchers found.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“That’s a concern from a public health standpoint, because it’s getting worse,” said Dima Qato, the study’s lead author from the University of Illinois at Chicago.

Qato and her colleagues previously reported that polypharmacy is common among older Americans. More than half were taking prescription and nonprescription medications between 2005 and 2006.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

There have been a lot of changes in U.S. regulations and the pharmacy market since that time, however. Some of those changes include new and less expensive generic drugs and the implementation of Medicare Part D, which is the prescription component of the government-run health insurance program for the elderly or disabled.

To evaluate the change in polypharmacy over time, the researchers compared the 2005-2006 results with data collected from 2010–2011.

Participants in the study were between the ages of 62 and 85 and were living at home. The researchers interviewed 2,351 people in 2005–2006 and 2,206 in 2010–2011.

Overall, about 67% were taking five or more medications or supplements in 2010–2011, up from about 53% in 2005–2006.

Use of cholesterol-lowering statins rose from about 34% to about 46%, the researchers report March 21 in JAMA Internal Medicine. The proportion of people taking blood-thinning medications also increased, from about 33% to 43%, and use of omega-3 fish oil pills rose from about 5% to about 19%.

Along with the increase in polypharmacy, the researchers found the risk of major drug interactions nearly doubled, going from about 8% to about 15%.

“I think we have to keep in mind that while it’s important to improve access to medications, we need to make sure they’re used safely,” said Qato.

On one hand, the new results can be seen as positive, said Dr. Michael Steinman, a gerontologist at the University of California, San Francisco.

“We’re treating more people with medications that could potentially help them,” he said. “But when people have four or five chronic conditions, medications quickly balloon to a large number.”

It’s important to ensure clear communication between everyone involved in a patient’s care, including the patient, said Steinman, who wrote an editorial accompanying the new study.

A separate study reported in the same issue of the journal found that nearly 42% of adults did not tell their doctors about the use of complementary or alternative medicine, which includes—among other things—supplements, herbs, homeopathy, special diets and acupuncture.

Page: 1 2 | Single Page
Share: 

Filed under:Drug UpdatesPractice Support Tagged with:agingdrug interactionMedicationMedication Managementpolypharmacyrisk

Related Articles

    How to Discuss Anti-Inflammatory Diets & Supplements with Your Patients

    June 9, 2023

    My patients ask me almost daily what kind of diet they should be on, or if there are certain supplements they should try. And a growing amount of evidence shows lifestyle and dietary factors may contribute to disease risk and outcomes in rheumatic disease. Thus, rheumatologists and rheumatology professionals are being called upon by patients…

    What Should Providers Do to Address Polypharmacy?

    January 17, 2020

    ATLANTA—In a session at the 2019 ACR/ARP Annual Meeting, Susan Chrostowski, DNP, assistant clinical professor at Texas Woman’s University College of Nursing, Dallas, told the audience that she’d had a visit with a patient and asked how he was doing. “Not too good,” he said, explaining that his chest hurt. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUE“What’s…

    How Celebrities, Senators, Dietary Supplements Muddle Medicine

    June 15, 2015

    It’s disheartening to stand by and watch helplessly as your patient dies a slow, painful death. In spring 1990, I had the misfortune of living through such a distressing experience. Strange happenings in New Mexico & Japan Ellen was a bookkeeper in her late 40s, living quietly in suburban Boston. For years, she hid a…

    How to Optimize Treatment for Aging Patients with Rheumatic Conditions

    August 30, 2023

    As patients with rheumatic musculoskeletal disease age, the number of medications they take may increase (i.e., polypharmacy), which can result in unwanted side effects and serious adverse effects. Lee et al. offer considerations and insights into caring for aging patients in a polypharmacy situation to better meet their health and lifestyle needs.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences